Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 20.2B | 18.6B | 19.2B | 19.1B |
Cost of revenue | 6.5B | 6.3B | 6.1B | 5.9B |
Gross profit | 13.7B | 12.4B | 13.1B | 13.2B |
Operating expense | ||||
Research & development | 3.0B | 2.7B | 4.5B | 4.2B |
Selling general and admin | 4.9B | 4.3B | 5.3B | 4.5B |
Other operating expenses | — | — | — | — |
Operating income | 5.8B | 5.4B | 3.3B | 4.5B |
Non operating interest income | ||||
Income | 221.4M | 282.7M | 239.2M | 248.6M |
Expense | 262.2M | 173.7M | 116.6M | 164.3M |
Other income expense | -224.8M | 6.1B | -50.2M | -1.7B |
Pretax income | 5.5B | 11.6B | 3.3B | 2.8B |
Tax provision | 812.2M | 2.2B | 388.2M | 548.3M |
Net income | 4.7B | 9.4B | 2.9B | 2.3B |
Basic EPS | 2.3 | 4.6 | 1.4 | 1.1 |
Diluted EPS | 2.3 | 4.5 | 1.4 | 1.1 |
Basic average shares | 2.0B | 2.0B | 2.0B | 2.0B |
Diluted average shares | 2.1B | 2.1B | 2.1B | 2.1B |
EBITDA | 7.8B | 7.4B | 5.1B | 6.7B |
Net income from continuing op. | 4.7B | 9.4B | 2.9B | 2.3B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |